TGFB1 and neoplasm: For instance, GBM promotes an immunosuppressive microenvironment through the release of TGF-β and IL-10, which recruit regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), inhibiting host anti-tumor immune cell activity [6].